It was our purpose to determine the characteristics of practitioners in the
United States who were among the first to inquire about and use the BRCA1
and BRCA2 (BRCA1/2) genetic tests outside of a research protocol. Questionn
aires were mailed to all practitioners who requested information on or orde
red a BRCA1/2 test from the University of Pennsylvania (UPenn) Genetic Diag
nostics Laboratory (GDL)between October 1, 1995 and January 1, 1997 (the fi
rst 15 months the test was available for clinical use).
The response rate was 67% of practitioners; 54% (121/225) were genetic coun
selors, 39% (87/225) were physicians or lab directors. Most physicians were
oncologists, pathologists, or obstetrician/gynecologists, but 20% practice
d surgery or internal or general medicine. Fifty-six percent (125/225) had
ordered a BRCA1/2 test for a patient; most of the rest had offered or were
willing to offer testing, Of those who had offered testing, 70% had a patie
nt decline BRCA1/2 testing when offered. Practitioners perceived that patie
nts' fear of loss of confidentiality was a major reason for declining, Near
ly 60% of practitioners reported that their patients had access to a geneti
c counselor, but 28% of physicians who ordered a BRCA1/2 test reported havi
ng no such access, despite the GDL's counseling requirement, The proportion
of physicians reporting no access to genetic counselors for their patients
increased from 22.4% in the first half of the study to 50% in the last hal
f. Many practitioners have an interest in BRCA1/2 testing, despite policy s
tatements that discourage its use outside of research protocols. Practition
er responses suggest that patient interest in testing seems to be tempered
by knowledge of potential risks. An apparent increase in patient concern ab
out confidentiality and inability to pay for testing could indicate growing
barriers to testing. Although most practitioners reported having access to
counseling facilities, perceived lack of such access among an increasing p
roportion of practitioners indicates that lab requirements for counseling a
re difficult to enforce and suggests that an increasing proportion of patie
nts may not be getting access to counseling. (C) 1999 Wiley-Liss, Inc.